22157.jpg
mRNA Therapeutics and Vaccines Market, 2030
March 25, 2021 06:03 ET | Research and Markets
Dublin, March 25, 2021 (GLOBE NEWSWIRE) -- The "mRNA Therapeutics and Vaccines Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering. The "mRNA Therapeutics and Vaccines...
22157.jpg
Global COVID-19 Vaccine Market Outlook and Forecast 2021-2024: Market Revenue is Expected to Reach a Value of US$5 Billion
March 24, 2021 08:48 ET | Research and Markets
Dublin, March 24, 2021 (GLOBE NEWSWIRE) -- The "COVID-19 Vaccine Market - Global Outlook and Forecast 2021-2024" report has been added to ResearchAndMarkets.com's offering. The global COVID-19...
22157.jpg
India COVID-19 Vaccines Market Report 2020-2027 - Major Players are Bharat Biotech, Serum Institute of India, Zydus Cadila, Biological E, Gennova Biopharmaceuticals & Dr. Reddy's Laboratories
February 26, 2021 06:23 ET | Research and Markets
Dublin, Feb. 26, 2021 (GLOBE NEWSWIRE) -- The "India COVID-19 Vaccines Market - Growth, Demand, Trends, Opportunity, Forecasts (2021 - 2027)" report has been added to ResearchAndMarkets.com's...
22157.jpg
Worldwide RNA Vaccine Patent Industry Report 2021 - Players Include CureVac, Moderna and BioNTech Among Others
January 28, 2021 08:23 ET | Research and Markets
Dublin, Jan. 28, 2021 (GLOBE NEWSWIRE) -- The "RNA Vaccine Patent Landscape 2021" report has been added to ResearchAndMarkets.com's offering. The idea of using mRNA as vaccines has been...
22157.jpg
Insights on the Pneumococcal Vaccine Global Market to 2025 - Competitive Analysis and the Impact of COVID-19
January 20, 2021 06:13 ET | Research and Markets
Dublin, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The "Global Pneumococcal Vaccine Market (2020-2025) by Type of Vaccine, Product, Sectors, Distribution Channel, Geography, Competitive Analysis and the...
22157.jpg
COVID-19 Pandemic Mitigation Products Market Worth $1.9 Trillion by 2024 - A Thorough Industry Analysis of 54 Products & Services, 6 Vertical, 4 Revenue Source, 5 Regional & 13 National Markets
January 07, 2021 11:28 ET | Research and Markets
Dublin, Jan. 07, 2021 (GLOBE NEWSWIRE) -- The "COVID-19 Pandemic Mitigation Products Market - 2020-2024" report has been added to ResearchAndMarkets.com's offering. According to the report, the...
Codex DNA Releases New Synthetic Genomes for the Fight Against COVID-19
December 01, 2020 10:15 ET | Codex
San Diego, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Codex DNA, Inc. today announced the release of seven new synthetic SARS-CoV-2 genomes for use in the development of vaccines, therapeutics, and...
22157.jpg
COVID-19 Vaccine Development, Therapeutics Experiments and Diagnostics/Devices Advances Analysis: A Round-up of Crucial Developments
October 27, 2020 05:23 ET | Research and Markets
Dublin, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The "COVID-19 - Vaccine Development, Therapeutics Experiments and Diagnostics/Devices Advances - Comprehensive Bundle" report has been added to...
GOVX new logo.png
GeoVax Announces License Agreement with NIH to Support COVID-19 Vaccine Development
October 26, 2020 09:00 ET | GeoVax, Inc.
ATLANTA, GA, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and...
22157.jpg
Global Influenza Vaccines Markets Report 2020: Quadrivalent is the Dominant Type of Influenza Vaccine - Forecast to 2028
October 01, 2020 04:49 ET | Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccines Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The global influenza vaccines market is...